
Prime Stock alert: Moving this pharma stock to a HOLD
Recent announcements relating to ownership change in this pharma stock prompt us to move this stock from a ‘BUY’ to a ‘HOLD’.

Recent announcements relating to ownership change in this pharma stock prompt us to move this stock from a ‘BUY’ to a ‘HOLD’.

A report from Kotak Institutional Equities sparked a bout of selling in mid and small caps. Should you be concerned? Here is what we think.

As stocks across market caps have run up, we are taking a look at Prime Stocks with a special focus on valuations and are moving these two stocks to a ‘HOLD’.

Results update for 5 of our Prime Stocks.

This commodity stock is well placed to play the changing tide in the sector on account of its affordable valuations.

Results update for 5 of our Prime Stocks

Consolidation and correction have made stocks of affordable housing finance companies attractive and this is our pick in the space.

results update for 5 of our Prime Stocks

We are moving an industrial sector stock that we recommended in June 2022, to a HOLD.

We are moving this Prime Stock to a HOLD and this report will explain why.

We think the time is right to partially sell your holdings of this API maker and hold the rest.

In part one of this four-part series we talk about examples of wrong entry into stocks with rich valuations and how to avoid them
Hold On
You are being redirected to another page,